Global and China Oxaprozin Market Insights, Forecast to 2027

Publisher Name :
Date: 20-Dec-2021
No. of pages: 143
Inquire Before Buying

Oxaprozin market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oxaprozin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Oxaprozin market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Tablets

- Capsule

Segment by Application

- Rheumatoid Arthritis

- Chronic Infectious Arthritis

- Osteoarthritis

- Ankylosing Spondylitis

- Neck Shoulder Wrist Syndrome

- Periarthritis Of Shoulder

- Gout

- Anti-Inflammatory and Analgesic Effects After Trauma and Surgery

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Pfizer

- Helsinn

- Taisho

- Ildong

- PD-Rx Pharmaceuticals

- Therapicon

- Neolpharma

- Apotex Corporation

- Yichang Dongyangguang Changjiang Pharmaceutical

- Hubei Baike Hengdi Pharmaceutical

- Fuan Pharmaceutical Group

- Hubei Baike Hengdi Pharmaceutical

- Pfizer

Global and China Oxaprozin Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Oxaprozin Product Introduction
1.2 Market by Type
1.2.1 Global Oxaprozin Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Capsule
1.3 Market by Application
1.3.1 Global Oxaprozin Market Size Growth Rate by Application
1.3.2 Rheumatoid Arthritis
1.3.3 Chronic Infectious Arthritis
1.3.4 Osteoarthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Neck Shoulder Wrist Syndrome
1.3.7 Periarthritis Of Shoulder
1.3.8 Gout
1.3.9 Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
1.3.10 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oxaprozin Market Size, Estimates and Forecasts
2.1.1 Global Oxaprozin Revenue 2016-2027
2.1.2 Global Oxaprozin Sales 2016-2027
2.2 Global Oxaprozin, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oxaprozin Historical Market Size by Region (2016-2021)
2.3.1 Global Oxaprozin Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oxaprozin Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oxaprozin Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oxaprozin Sales Forecast by Region (2022-2027)
2.4.2 Global Oxaprozin Revenue Forecast by Region (2022-2027)
3 Global Oxaprozin Competitor Landscape by Players
3.1 Global Top Oxaprozin Manufacturers by Sales
3.1.1 Global Oxaprozin Sales by Manufacturer (2016-2021)
3.1.2 Global Oxaprozin Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oxaprozin Manufacturers by Revenue
3.2.1 Key Oxaprozin Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oxaprozin Revenue by Manufacturers (2016-2021)
3.2.3 Global Oxaprozin Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oxaprozin Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oxaprozin Revenue in 2020
3.2.6 Global Oxaprozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oxaprozin Price by Manufacturers
3.4 Global Oxaprozin Manufacturing Base Distribution, Product Types
3.4.1 Oxaprozin Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oxaprozin Product Type
3.4.3 Date of International Manufacturers Enter into Oxaprozin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oxaprozin Market Size by Type (2016-2021)
4.1.1 Global Oxaprozin Sales by Type (2016-2021)
4.1.2 Global Oxaprozin Revenue by Type (2016-2021)
4.1.3 Oxaprozin Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oxaprozin Market Size Forecast by Type (2022-2027)
4.2.1 Global Oxaprozin Sales Forecast by Type (2022-2027)
4.2.2 Global Oxaprozin Revenue Forecast by Type (2022-2027)
4.2.3 Oxaprozin Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oxaprozin Market Size by Application (2016-2021)
5.1.1 Global Oxaprozin Sales by Application (2016-2021)
5.1.2 Global Oxaprozin Revenue by Application (2016-2021)
5.1.3 Oxaprozin Price by Application (2016-2021)
5.2 Oxaprozin Market Size Forecast by Application (2022-2027)
5.2.1 Global Oxaprozin Sales Forecast by Application (2022-2027)
5.2.2 Global Oxaprozin Revenue Forecast by Application (2022-2027)
5.2.3 Global Oxaprozin Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Oxaprozin Market Size YoY Growth 2016-2027
6.1.1 China Oxaprozin Sales YoY Growth 2016-2027
6.1.2 China Oxaprozin Revenue YoY Growth 2016-2027
6.1.3 China Oxaprozin Market Share in Global Market 2016-2027
6.2 China Oxaprozin Market Size by Players (International and Local Players)
6.2.1 China Top Oxaprozin Players by Sales (2016-2021)
6.2.2 China Top Oxaprozin Players by Revenue (2016-2021)
6.3 China Oxaprozin Historic Market Review by Type (2016-2021)
6.3.1 China Oxaprozin Sales Market Share by Type (2016-2021)
6.3.2 China Oxaprozin Revenue Market Share by Type (2016-2021)
6.3.3 China Oxaprozin Price by Type (2016-2021)
6.4 China Oxaprozin Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Oxaprozin Sales Forecast by Type (2022-2027)
6.4.2 China Oxaprozin Revenue Forecast by Type (2022-2027)
6.4.3 China Oxaprozin Price Forecast by Type (2022-2027)
6.5 China Oxaprozin Historic Market Review by Application (2016-2021)
6.5.1 China Oxaprozin Sales Market Share by Application (2016-2021)
6.5.2 China Oxaprozin Revenue Market Share by Application (2016-2021)
6.5.3 China Oxaprozin Price by Application (2016-2021)
6.6 China Oxaprozin Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Oxaprozin Sales Forecast by Application (2022-2027)
6.6.2 China Oxaprozin Revenue Forecast by Application (2022-2027)
6.6.3 China Oxaprozin Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oxaprozin Market Size YoY Growth 2016-2027
7.2 North America Oxaprozin Market Facts & Figures by Country
7.2.1 North America Oxaprozin Sales by Country (2016-2021)
7.2.2 North America Oxaprozin Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oxaprozin Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oxaprozin Market Facts & Figures by Region
8.2.1 Asia Pacific Oxaprozin Sales by Region (2016-2021)
8.2.2 Asia Pacific Oxaprozin Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oxaprozin Market Size YoY Growth 2016-2027
9.2 Europe Oxaprozin Market Facts & Figures by Country
9.2.1 Europe Oxaprozin Sales by Country (2016-2021)
9.2.2 Europe Oxaprozin Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oxaprozin Market Size YoY Growth 2016-2027
10.2 Latin America Oxaprozin Market Facts & Figures by Country
10.2.1 Latin America Oxaprozin Sales by Country (2016-2021)
10.2.2 Latin America Oxaprozin Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oxaprozin Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oxaprozin Market Facts & Figures by Country
11.2.1 Middle East and Africa Oxaprozin Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oxaprozin Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Pfizer Oxaprozin Products Offered
12.1.5 Pfizer Recent Development
12.2 Helsinn
12.2.1 Helsinn Corporation Information
12.2.2 Helsinn Description and Business Overview
12.2.3 Helsinn Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Helsinn Oxaprozin Products Offered
12.2.5 Helsinn Recent Development
12.3 Taisho
12.3.1 Taisho Corporation Information
12.3.2 Taisho Description and Business Overview
12.3.3 Taisho Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Taisho Oxaprozin Products Offered
12.3.5 Taisho Recent Development
12.4 Ildong
12.4.1 Ildong Corporation Information
12.4.2 Ildong Description and Business Overview
12.4.3 Ildong Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Ildong Oxaprozin Products Offered
12.4.5 Ildong Recent Development
12.5 PD-Rx Pharmaceuticals
12.5.1 PD-Rx Pharmaceuticals Corporation Information
12.5.2 PD-Rx Pharmaceuticals Description and Business Overview
12.5.3 PD-Rx Pharmaceuticals Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.5.4 PD-Rx Pharmaceuticals Oxaprozin Products Offered
12.5.5 PD-Rx Pharmaceuticals Recent Development
12.6 Therapicon
12.6.1 Therapicon Corporation Information
12.6.2 Therapicon Description and Business Overview
12.6.3 Therapicon Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Therapicon Oxaprozin Products Offered
12.6.5 Therapicon Recent Development
12.7 Neolpharma
12.7.1 Neolpharma Corporation Information
12.7.2 Neolpharma Description and Business Overview
12.7.3 Neolpharma Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Neolpharma Oxaprozin Products Offered
12.7.5 Neolpharma Recent Development
12.8 Apotex Corporation
12.8.1 Apotex Corporation Corporation Information
12.8.2 Apotex Corporation Description and Business Overview
12.8.3 Apotex Corporation Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Apotex Corporation Oxaprozin Products Offered
12.8.5 Apotex Corporation Recent Development
12.9 Yichang Dongyangguang Changjiang Pharmaceutical
12.9.1 Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
12.9.2 Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
12.9.3 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Products Offered
12.9.5 Yichang Dongyangguang Changjiang Pharmaceutical Recent Development
12.10 Hubei Baike Hengdi Pharmaceutical
12.10.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
12.10.2 Hubei Baike Hengdi Pharmaceutical Description and Business Overview
12.10.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Hubei Baike Hengdi Pharmaceutical Oxaprozin Products Offered
12.10.5 Hubei Baike Hengdi Pharmaceutical Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Pfizer Oxaprozin Products Offered
12.11.5 Pfizer Recent Development
12.12 Hubei Baike Hengdi Pharmaceutical
12.12.1 Hubei Baike Hengdi Pharmaceutical Corporation Information
12.12.2 Hubei Baike Hengdi Pharmaceutical Description and Business Overview
12.12.3 Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hubei Baike Hengdi Pharmaceutical Products Offered
12.12.5 Hubei Baike Hengdi Pharmaceutical Recent Development
12.31 Pfizer
12.31.1 Pfizer Corporation Information
12.31.2 Pfizer Description and Business Overview
12.31.3 Pfizer Oxaprozin Sales, Revenue and Gross Margin (2016-2021)
12.31.4 Pfizer Products Offered
12.31.5 Pfizer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oxaprozin Industry Trends
13.2 Oxaprozin Market Drivers
13.3 Oxaprozin Market Challenges
13.4 Oxaprozin Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oxaprozin Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Oxaprozin Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsule
Table 4. Global Oxaprozin Market Size Growth Rate by Application (2021-2027) & (KG)
Table 5. Global Oxaprozin Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Oxaprozin Sales by Regions (2016-2021) & (KG)
Table 7. Global Oxaprozin Sales Market Share by Regions (2016-2021)
Table 8. Global Oxaprozin Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Oxaprozin Sales Forecast by Region (2022-2027) & (KG)
Table 10. Global Oxaprozin Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Oxaprozin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Oxaprozin Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Oxaprozin Sales by Manufacturers (2016-2021) (KG)
Table 14. Global Oxaprozin Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Oxaprozin Manufacturers by Revenue (US$ Million) in 2020
Table 16. Oxaprozin Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Oxaprozin Revenue Share by Manufacturers (2016-2021)
Table 18. Global Oxaprozin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Oxaprozin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oxaprozin as of 2020)
Table 20. Key Manufacturers Oxaprozin Price (2016-2021) (US$/G)
Table 21. Oxaprozin Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Oxaprozin Product Type
Table 23. Date of International Manufacturers Enter into Oxaprozin Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Oxaprozin Sales by Type (2016-2021) (KG)
Table 26. Global Oxaprozin Sales Share by Type (2016-2021)
Table 27. Global Oxaprozin Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Oxaprozin Revenue Share by Type (2016-2021)
Table 29. Oxaprozin Average Selling Price (ASP) by Type (2016-2021) & (US$/G)
Table 30. Global Oxaprozin Sales Forecast by Type (2022-2027) & (KG)
Table 31. Global Oxaprozin Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Oxaprozin Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Oxaprozin Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Oxaprozin Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G)
Table 35. Global Oxaprozin Sales by Application (2016-2021) (KG)
Table 36. Global Oxaprozin Sales Share by Application (2016-2021)
Table 37. Global Oxaprozin Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Oxaprozin Revenue Share by Application (2016-2021)
Table 39. Oxaprozin Average Selling Price (ASP) by Application (2016-2021) & (US$/G)
Table 40. Global Oxaprozin Sales Forecast by Application (2022-2027) & (KG)
Table 41. Global Oxaprozin Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Oxaprozin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Oxaprozin Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Oxaprozin Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G)
Table 45. China Oxaprozin Sales (KG) of Key Companies (2016-2021)
Table 46. China Oxaprozin Sales Share by Company (2016-2021)
Table 47. China Oxaprozin Revenue (US$ Million) by Company (2016-2021)
Table 48. China Oxaprozin Revenue Share by Company (2016-2021)
Table 49. China Oxaprozin Sales (KG) by Type (2016-2021)
Table 50. China Oxaprozin Sales Share by Type (2016-2021)
Table 51. China Oxaprozin Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Oxaprozin Price (US$/G) by Type (2016-2021)
Table 53. China Oxaprozin Sales (KG) by Type (2022-2027)
Table 54. China Oxaprozin Sales Share by Type (2022-2027)
Table 55. China Oxaprozin Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Oxaprozin Revenue Share by Type (2022-2027)
Table 57. China Oxaprozin Price (US$/G) by Type (2022-2027)
Table 58. China Oxaprozin Sales (KG) by Application (2016-2021)
Table 59. China Oxaprozin Sales Share by Application (2016-2021)
Table 60. China Oxaprozin Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Oxaprozin Price (US$/G) by Application (2016-2021)
Table 62. China Oxaprozin Sales (KG) by Application (2022-2027)
Table 63. China Oxaprozin Sales Share by Application (2022-2027)
Table 64. China Oxaprozin Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Oxaprozin Revenue Share by Application (2022-2027)
Table 66. China Oxaprozin Price (US$/G) by Application (2022-2027)
Table 67. North America Oxaprozin Sales by Country (2016-2021) & (KG)
Table 68. North America Oxaprozin Sales Market Share by Country (2016-2021)
Table 69. North America Oxaprozin Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Oxaprozin Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Oxaprozin Sales by Region (2016-2021) & (KG)
Table 72. Asia Pacific Oxaprozin Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Oxaprozin Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Oxaprozin Revenue Market Share by Region (2016-2021)
Table 75. Europe Oxaprozin Sales by Country (2016-2021) & (KG)
Table 76. Europe Oxaprozin Sales Market Share by Country (2016-2021)
Table 77. Europe Oxaprozin Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Oxaprozin Revenue Market Share by Country (2016-2021)
Table 79. Latin America Oxaprozin Sales by Country (2016-2021) & (KG)
Table 80. Latin America Oxaprozin Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Oxaprozin Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Oxaprozin Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Oxaprozin Sales by Country (2016-2021) & (KG)
Table 84. Middle East and Africa Oxaprozin Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Oxaprozin Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Oxaprozin Revenue Market Share by Country (2016-2021)
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Business Overview
Table 89. Pfizer Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 90. Pfizer Oxaprozin Product
Table 91. Pfizer Recent Development
Table 92. Helsinn Corporation Information
Table 93. Helsinn Description and Business Overview
Table 94. Helsinn Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 95. Helsinn Product
Table 96. Helsinn Recent Development
Table 97. Taisho Corporation Information
Table 98. Taisho Description and Business Overview
Table 99. Taisho Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 100. Taisho Product
Table 101. Taisho Recent Development
Table 102. Ildong Corporation Information
Table 103. Ildong Description and Business Overview
Table 104. Ildong Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 105. Ildong Product
Table 106. Ildong Recent Development
Table 107. PD-Rx Pharmaceuticals Corporation Information
Table 108. PD-Rx Pharmaceuticals Description and Business Overview
Table 109. PD-Rx Pharmaceuticals Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 110. PD-Rx Pharmaceuticals Product
Table 111. PD-Rx Pharmaceuticals Recent Development
Table 112. Therapicon Corporation Information
Table 113. Therapicon Description and Business Overview
Table 114. Therapicon Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 115. Therapicon Product
Table 116. Therapicon Recent Development
Table 117. Neolpharma Corporation Information
Table 118. Neolpharma Description and Business Overview
Table 119. Neolpharma Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 120. Neolpharma Product
Table 121. Neolpharma Recent Development
Table 122. Apotex Corporation Corporation Information
Table 123. Apotex Corporation Description and Business Overview
Table 124. Apotex Corporation Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 125. Apotex Corporation Product
Table 126. Apotex Corporation Recent Development
Table 127. Yichang Dongyangguang Changjiang Pharmaceutical Corporation Information
Table 128. Yichang Dongyangguang Changjiang Pharmaceutical Description and Business Overview
Table 129. Yichang Dongyangguang Changjiang Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 130. Yichang Dongyangguang Changjiang Pharmaceutical Product
Table 131. Yichang Dongyangguang Changjiang Pharmaceutical Recent Development
Table 132. Hubei Baike Hengdi Pharmaceutical Corporation Information
Table 133. Hubei Baike Hengdi Pharmaceutical Description and Business Overview
Table 134. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 135. Hubei Baike Hengdi Pharmaceutical Product
Table 136. Hubei Baike Hengdi Pharmaceutical Recent Development
Table 137. Fuan Pharmaceutical Group Corporation Information
Table 138. Fuan Pharmaceutical Group Description and Business Overview
Table 139. Fuan Pharmaceutical Group Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 140. Fuan Pharmaceutical Group Product
Table 141. Fuan Pharmaceutical Group Recent Development
Table 142. Hubei Baike Hengdi Pharmaceutical Corporation Information
Table 143. Hubei Baike Hengdi Pharmaceutical Description and Business Overview
Table 144. Hubei Baike Hengdi Pharmaceutical Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 145. Hubei Baike Hengdi Pharmaceutical Product
Table 146. Hubei Baike Hengdi Pharmaceutical Recent Development
Table 147. Pfizer Corporation Information
Table 148. Pfizer Description and Business Overview
Table 149. Pfizer Oxaprozin Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 150. Pfizer Product
Table 151. Pfizer Recent Development
Table 152. Oxaprozin Market Trends
Table 153. Oxaprozin Market Drivers
Table 154. Oxaprozin Market Challenges
Table 155. Oxaprozin Market Restraints
Table 156. Oxaprozin Customers List
Table 157. Oxaprozin Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Oxaprozin Product Picture
Figure 2. Global Oxaprozin Sales Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Oxaprozin Sales Market Share by Application in 2020 & 2027
Figure 6. Rheumatoid Arthritis
Figure 7. Chronic Infectious Arthritis
Figure 8. Osteoarthritis
Figure 9. Ankylosing Spondylitis
Figure 10. Neck Shoulder Wrist Syndrome
Figure 11. Periarthritis Of Shoulder
Figure 12. Gout
Figure 13. Anti-Inflammatory and Analgesic Effects After Trauma and Surgery
Figure 14. Other
Figure 15. Oxaprozin Report Years Considered
Figure 16. Global Oxaprozin Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Oxaprozin Market Size 2016-2027 (US$ Million)
Figure 18. Global Oxaprozin Sales 2016-2027 (KG)
Figure 19. Global Oxaprozin Market Size Market Share by Region: 2021 Versus 2027
Figure 20. Global Oxaprozin Sales Market Share by Region (2016-2021)
Figure 21. Global Oxaprozin Sales Market Share by Region in 2020
Figure 22. Global Oxaprozin Revenue Market Share by Region (2016-2021)
Figure 23. Global Oxaprozin Revenue Market Share by Region in 2020
Figure 24. Global Oxaprozin Sales Share by Manufacturer in 2020
Figure 25. The Top 10 and 5 Players Market Share by Oxaprozin Revenue in 2020
Figure 26. Oxaprozin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 27. Global Oxaprozin Sales Market Share by Type (2016-2021)
Figure 28. Global Oxaprozin Sales Market Share by Type in 2020
Figure 29. Global Oxaprozin Revenue Market Share by Type (2016-2021)
Figure 30. Global Oxaprozin Revenue Market Share by Type in 2020
Figure 31. Global Oxaprozin Sales Market Share by Application (2016-2021)
Figure 32. Global Oxaprozin Sales Market Share by Application in 2020
Figure 33. Global Oxaprozin Revenue Market Share by Application (2016-2021)
Figure 34. Global Oxaprozin Revenue Market Share by Application in 2020
Figure 35. China Oxaprozin Sales Growth Rate 2016-2027 (KG)
Figure 36. China Oxaprozin Revenue Growth Rate 2016-2027 (US$ Million)
Figure 37. China Oxaprozin Market Share in Global Market 2016-2027
Figure 38. China 5 and 10 Largest Oxaprozin Players Market Share by Revenue in Oxaprozin in 2020
Figure 39. China Oxaprozin Revenue Share by Type (2016-2021)
Figure 40. China Oxaprozin Revenue Growth Rate by Type in 2016 & 2020
Figure 41. China Oxaprozin Revenue Share by Application (2016-2021)
Figure 42. China Oxaprozin Revenue Growth Rate by Application in 2016 & 2020
Figure 43. North America Oxaprozin Sales Growth Rate 2016-2021 (KG)
Figure 44. North America Oxaprozin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 45. North America Oxaprozin Sales Market Share by Country in 2020
Figure 46. North America Oxaprozin Revenue Market Share by Country in 2020
Figure 47. U.S. Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 48. U.S. Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Canada Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 50. Canada Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Europe Oxaprozin Sales Growth Rate 2016-2021 (KG)
Figure 52. Europe Oxaprozin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 53. Europe Oxaprozin Sales Market Share by Country in 2020
Figure 54. Europe Oxaprozin Revenue Market Share by Country in 2020
Figure 55. Germany Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 56. Germany Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. France Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 58. France Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. U.K. Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 60. U.K. Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Italy Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 62. Italy Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Russia Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 64. Russia Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Asia Pacific Oxaprozin Sales Growth Rate 2016-2021 (KG)
Figure 66. Asia Pacific Oxaprozin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 67. Asia Pacific Oxaprozin Sales Market Share by Region in 2020
Figure 68. Asia Pacific Oxaprozin Revenue Market Share by Region in 2020
Figure 69. China Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 70. China Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Japan Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 72. Japan Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. South Korea Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 74. South Korea Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. India Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 76. India Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Australia Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 78. Australia Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Taiwan Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 80. Taiwan Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Indonesia Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 82. Indonesia Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Thailand Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 84. Thailand Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Malaysia Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 86. Malaysia Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Philippines Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 88. Philippines Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 89. Vietnam Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 90. Vietnam Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Latin America Oxaprozin Sales Growth Rate 2016-2021 (KG)
Figure 92. Latin America Oxaprozin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 93. Latin America Oxaprozin Sales Market Share by Country in 2020
Figure 94. Latin America Oxaprozin Revenue Market Share by Country in 2020
Figure 95. Mexico Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 96. Mexico Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Brazil Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 98. Brazil Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 99. Argentina Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 100. Argentina Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Middle East and Africa Oxaprozin Sales Growth Rate 2016-2021 (KG)
Figure 102. Middle East and Africa Oxaprozin Revenue Growth Rate 2016-2021 (US$ Million)
Figure 103. Middle East and Africa Oxaprozin Sales Market Share by Country in 2020
Figure 104. Middle East and Africa Oxaprozin Revenue Market Share by Country in 2020
Figure 105. Turkey Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 106. Turkey Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Saudi Arabia Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 108. Saudi Arabia Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 109. UAE Oxaprozin Sales Growth Rate (2016-2021) (KG)
Figure 110. UAE Oxaprozin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 111. Oxaprozin Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs